Pediatric Rheumatology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: peds rheum, pediatric rheumatology. Subspecialty fellowship of Pediatrics. Organ systems: joints, connective tissue, and the immune system, covering the autoimmune and autoinflammatory diseases of childhood.

The 30-second version

Pediatric rheumatology is the cerebral, longitudinal, mission-heavy corner of pediatrics, the field for the diagnostic-puzzle lover who wants to follow the same complex kids for years and, thanks to modern biologics, actually watch them get better. You work up the child with fevers no one can explain, the swollen joints plus rash plus strange labs, the new lupus flare; you diagnose and manage juvenile arthritis, childhood lupus, dermatomyositis, vasculitis, autoinflammatory syndromes, and chronic uveitis; and you titrate the immunosuppressants and biologics that increasingly turn a limping, exhausted kid back into a kid. It's overwhelmingly outpatient, light on call, and famous within pediatrics for a humane lifestyle, but it's also one of the lowest-paid fields in all of medicine, earning below general pediatrics despite three extra fellowship years, and it sits at the center of one of the worst workforce shortages in American medicine. That combination is the whole personality of the field: deep meaning and a sane schedule, wrapped around modest pay and a nationwide access crisis.

Quick dashboard (details and sources below)


Training after med school	Peds residency (3) + Peds Rheum fellowship (3) = 6 yrs after med school
Total from college start	~14 years (4 undergrad + 4 med school + 3 residency + 3 fellowship)
Competitiveness (as a peds subspecialty)	Among the least competitive/least-filled fellowships in medicine (~54% fill, 2026) ⟳
Typical full-time pay	~$231,000 (Doximity 2025) — below general pediatrics ⟳
Pay range (structure)	~$150k–$180k academic assistant-prof base band · senior/leadership higher; ceilings well below procedural peds ⟳
Lifestyle	Outpatient-dominant, Mon–Fri, light and low-intensity call — among the most controllable in pediatrics
Burnout	Drivers are understaffing & prior-auth battles rather than hours. No rheumatology row on either survey, so this page reads the general-pediatrics proxy at 51% (Medscape 2024, 49% average); "lower-risk than high-acuity peds" is a reading of the schedule, not a measurement ⟳
% women	80.2% of fellows (AY2024-25); no figure published for the practicing workforce ⟳
DO / IMG accessibility	~30% DO, ~22% IMG/foreign of matched fellows (2025) — very open, by way of undersubscription ⟳

Two-step entry note: you do not match into Peds Rheum out of medical school. You first match into a general pediatrics residency (an accessible and unusually IMG-friendly route), then apply again during residency to a Peds Rheum fellowship through the NRMP Medicine & Pediatric Specialties Match.

What they actually do

Pediatric rheumatologists diagnose and manage autoimmune, autoinflammatory, and inflammatory diseases of the joints, connective tissue, and immune system in children and adolescents.¹ The core diseases are juvenile idiopathic arthritis (JIA) and other chronic childhood arthritis, childhood-onset lupus and the connective-tissue diseases (scleroderma, dermatomyositis, Sjögren, mixed connective tissue disease), the vasculitides (Kawasaki disease, IgA vasculitis, ANCA-associated, Behçet), the autoinflammatory and periodic-fever syndromes (PFAPA and the monogenic periodic fevers), and chronic non-infectious uveitis, plus MIS-C evaluations and chronic or amplified musculoskeletal pain.¹ Because almost all of these are chronic, the field is built on longitudinal continuity (you follow the same medically complex children for years, sometimes into young adulthood) and multidisciplinary care (close loops with ophthalmology for uveitis, plus dermatology, orthopedics, nephrology, and PT/OT).¹

The core skill is diagnostic synthesis: being the detective on the febrile, multi-system, undifferentiated child other specialists couldn't figure out, and then managing years-long immunosuppressive and biologic therapy. This is a thinker's specialty, not a proceduralist's: the hands-on work is limited mostly to joint injections/arthrocentesis and a growing use of point-of-care musculoskeletal ultrasound.¹

Representative procedures: joint aspiration (arthrocentesis) · intra-articular corticosteroid injections (often with sedation/ultrasound guidance) · musculoskeletal ultrasound · ordering/interpreting MRI, X-ray, and lab studies · coordinating (with other services) skin/muscle biopsy and other diagnostic workups. Much of the "procedural" load is really infusion oversight: supervising and adjusting biologic and immunosuppressive infusions (infliximab, rituximab, cyclophosphamide, IVIG).¹

A week in the life: Predominantly a Monday–Friday, clinic-based life. The bulk is longitudinal continuity clinic, with new consults and, more often, return visits for chronically ill children whose disease is monitored and titrated over months to years.² Layered on top: inpatient consults to the wards, PICU, and ED (new-onset lupus, systemic JIA with macrophage activation syndrome, vasculitis, fevers of unknown origin, MIS-C), infusion-center oversight, in-clinic joint injections, and, because ABP certification requires scholarly work, protected time for research, QI, or teaching for many practitioners.²³ Self-reported hours cluster around 40–55/week depending on research and clinic load; the days are cognitively dense, but the shape of the week is predictable.²

The training path & time to completion

Medical school (4 yrs) → general Pediatrics residency (3 yrs) → Pediatric Rheumatology fellowship (3 yrs) → board-eligible with the American Board of Pediatrics (ABP) in Pediatric Rheumatology.³ This is a two-step entry: you match into pediatrics residency straight from medical school, then apply again during residency to a 3-year fellowship through the NRMP Medicine and Pediatric Specialties (Fall) Match.³⁴ (The field is also reachable via a Med-Peds residency.)

Fellowship (3 yrs): ACGME-accredited (RCPSC in Canada), with a required scholarly-activity and research component. The three years typically combine core clinical training (concentrated early, plus continuity clinic throughout) with substantial protected time for research/scholarship in the later years.³
Board: the American Board of Pediatrics (ABP), whose subspecialty certification in Pediatric Rheumatology requires ABP general-pediatrics certification first, completion of the accredited 3-year fellowship, and passing the sub-board exam.³
A completely separate pathway from adult rheumatology, which runs through Internal Medicine and a 2-year ABIM fellowship. Peds rheum is its own training chain rather than a shorter or longer version of the adult field.³⁵
Total from the start of college: ~14 years (4 undergrad + 4 med school + 3 residency + 3 fellowship); 6 years after medical school.³

How competitive is it?

The single most important thing a premed should understand about this field is that getting in is not the challenge. Pediatric rheumatology is chronically, severely undersubscribed, one of the least-filled fellowships in all of American graduate medical education and the near-opposite of adult rheumatology, which fills ~99%.⁴ The accessible front door is general pediatrics residency, one of the more open, DO/IMG-friendly routes in medicine, and the fellowship step, uniquely, is easier still because there aren't enough applicants to go around.⁶⁴

Recent match cycles (via the NRMP Medicine & Pediatric Specialties Match):⁴

Appointment year	Programs	Positions	Filled	Fill rate
2026	33	44	24	54.5% ⟳
2025	36	55	27	49.1% ⟳
2024	—	52	32	61.5%
2023	—	43	27	62.8%
2022	—	39	27	69.2%

The shape is the finding. The fill rate has fallen in four of the last five cycles, from 69.2% to 54.5%, and the number of fellows entering the field has not risen once: 27, 27, 32, 27, 24. That is a slow, consistent decline rather than one bad year, which is what makes the access crisis below a structural problem rather than a blip.⁴ ⟳
About half of all pediatric rheumatology fellowship positions go unfilled every year, and roughly half of programs fail to fill.⁴ ⟳
The higher percentage in 2026 (54.5% vs. 49.1%) is misleading: programs cut offered positions (55 → 44). The ACR explicitly noted that if 2025's position count had held, the 2026 fill rate would have declined, so both capacity and applicant interest are shrinking.⁴ ⟳
Applicant-to-position ratio is well below 1.0. There are fewer applicants than seats. A pediatric-subspecialty-wide analysis put rheumatology at ~0.62 applicants per position (2024), among the lowest of any pediatric subspecialty; only ~24–33 applicants rank the field each year, and interest is declining (top-choice applicants fell ~14% since 2022).⁷⁴ ⟳
Composition of matched fellows (2025): of 27 matched, ~13 US MD, ~8 DO (~30%), and ~6 IMG/foreign (~22%). This is a field that is a meaningful net importer of DO and IMG applicants, driven purely by open positions.⁴ ⟳

The honest read: the difficulty here is not the match but the pipeline: too few pediatricians choose the field, largely for the compensation and training-length reasons below. For a student building steadily toward it, the path is unusually forgiving. Program leaders describe the steady trickle of applicants as "insufficient…for our current needs, much less for the future."⁴

Compensation — the robust version

Peds rheum pay is moderately documented but genuinely uncertain, because it's a tiny, overwhelmingly academic field with small survey samples and inconsistent definitions (base vs. total comp). Lean on the pattern, not any single point estimate.⁵

Where it sits, in one blunt line. Pediatric rheumatology is one of the lowest-paid physician fields in the United States, full stop, and it pays less than general pediatrics despite three additional years of low-paid fellowship.⁵

National number. Doximity 2025 (2024 data): ~$231,574, about $33,656 below general pediatrics ($265,230).⁵ A job-board aggregator (ZipRecruiter) estimates ~$313k, but academic and children's-hospital reality generally runs well below that; treat job-board figures as rough and high.² A defensible "typical" figure is near or just above $231k, and below general peds. ⟳

The "fellowship pay penalty," in a table. Doximity's own numbers show five pediatric subspecialties earning less than general pediatrics; peds rheum is second-lowest:⁵

Pediatric subspecialty (3 extra fellowship yrs)	Comp (Doximity 2025 / 2024 data)	vs. general peds ($265,230)
Pediatric Endocrinology	$230,426	−$34,804
Pediatric Rheumatology	$231,574	−$33,656
Pediatric Infectious Disease	$248,322	−$16,908
Pediatric Hematology/Oncology	$255,733	−$9,497
Pediatric Nephrology	$263,013	≈ equal
General Pediatrics	$265,230	—

Doximity's commentary groups the below-general-peds outpatient fields under the mnemonic "READING": Rheumatology, Endocrinology, Adolescent medicine, Developmental-behavioral, Infectious disease, Nephrology, and Genetics. All are cognitive, non-procedural, and therefore low in the wRVU productivity that drives physician pay.⁵

Why so low (structural). These fields generate few high-RVU procedures; the work is almost entirely cognitive and outpatient, so billing productivity is intrinsically low. Pediatrics also carries a Medicaid drag, since more than half of US children are on Medicaid, which reimburses below cost.⁵ And critically, peds rheum has no infusion/"buy-and-bill" income lever: the biologics are delivered in hospital infusion centers, not physician-owned clinics, so the revenue that pads adult rheumatology income is essentially unavailable.⁵

Academic base, because it's an academic field. More than 72% of pediatric rheumatologists work at teaching hospitals, so compensation is an academic-salary story rather than a private-practice one.⁸ A peds-rheum-specific assistant-professor base wasn't published as a clean number (limited data), but the comparable "READING"-tier peds ID assistant professor was cited at $147k–$158k, or "less than a new computer-science bachelor's grad," so expect roughly a $150k–$180k academic base band, rising modestly with rank, tenure, and division-chief/leadership roles, but with ceilings well below procedural peds.⁵ ⟳

Geography / urban vs. rural. State- and region-level peds-rheum tables essentially don't exist (the workforce is too small to break out; limited data). Structurally, the field is concentrated in urban academic children's hospitals; there is effectively no rural private-practice market. This is an access-desert specialty where rural children travel to the specialist, rather than one with a rural pay premium.⁵⁸ ⟳

The adult-rheumatology contrast. Adult rheumatology is itself lower-middle on the IM pay ladder, yet it clearly out-earns the pediatric field: ~$284k (Medscape 2026) to ~$325k (Doximity 2025), a defensible "typical" ~$300k, plus the in-office infusion revenue peds rheum can't access. Net: an adult rheumatologist out-earns a pediatric one by roughly $55k–$90k+, for shorter training (a 2-year IM fellowship vs. a 3-year peds fellowship).⁵ ⟳

The number that colors everything is lifetime earnings. Peer-reviewed work shows that most pediatric subspecialties, including rheumatology, carry a negative lifetime financial return versus simply practicing general pediatrics: you spend ~3 extra fellowship years at trainee pay for a salary that often doesn't exceed general peds. In one analysis, 12 of 15 pediatric subspecialties had negative lifetime returns, and the best-vs-worst gap across pediatric paths widened to over $2.3 million (2018–2019 data). Lower pay also correlated with worse workforce growth and access, and peds rheum is the textbook case.⁹ ⟳

Compensation bottom line: ~$231k, below general pediatrics and near the bottom of all physician pay, after three extra fellowship years that, on average, reduce lifetime earnings versus stopping at general peds. Almost entirely academic; no infusion lever. This field is chosen for the patients, the puzzle, and the mission rather than the money, which is worth internalizing before you fall in love with it.

Lifestyle & the schedule bargain

The most-cited pro of peds rheum: it's one of the most schedule-controllable fields in all of pediatrics.² The practice is predominantly outpatient, Monday–Friday continuity clinic, and the field is widely regarded within pediatrics as a "sane call" subspecialty.

Call is light and low-intensity. Most patients are outpatient and chronic; acute overnight emergencies are relatively uncommon versus NICU, PICU, cardiology, or heme/onc. Inpatient consults exist (new lupus, systemic JIA/MAS, vasculitis, fevers), but the intensity of call is usually low. The honest caveat: because groups are often small (see the workforce crisis), call frequency per person can run higher at a lean center, even if each call is rarely a crisis.²
Schedule control is high, and the field is among the most compatible in pediatrics with part-time and flexible scheduling. The workforce literature explicitly names work-life balance and part-time availability as recruitment/retention levers.²⁸
Continuity is deep. You become a fixture in families' lives across years of a child's development, which is the payoff for people who find meaning in relationships, and a real emotional weight to carry over the long haul.²

Lifestyle rating: 4.5/5. Among the most controllable in pediatrics. The honest caveat is that the daily drag here is prior-authorization battles to get expensive biologics approved, understaffing, and waitlists you can't clear, rather than chaos or hours.

Wellbeing — the part to take seriously

Meaning runs unusually high. The dominant theme in the field's identity is that biologics turned peds rheum into a "results" specialty. Kids who a generation ago faced joint destruction, wheelchairs, uveitis-driven blindness, or organ damage now frequently reach remission on TNF/IL-1/IL-6 blockade. Practitioners describe watching a limping, exhausted child return to school and sports; combined with an enormous unmet need (you are often the only pediatric rheumatologist a family could reach), the sense of purpose is a repeatedly cited reason people stay.²

The burnout drivers here are unusual, and the schedule is not among them. They are being under-staffed (long waitlists, being stretched thin by demand), insurance and prior-auth friction (a real, recurring tax precisely because the effective drugs are costly), and the isolation of practicing solo or in a small group far from colleagues.² Dissatisfaction, when it appears, clusters around compensation, isolation, and demand rather than around the medicine.² Nobody has published a would-choose-again figure by specialty since about 2019, so there is none to quote.

What is measured here, and what is a reading of the schedule. This field has long been described as lower-risk than the high-acuity, high-call pediatric specialties, and that is a reading of how the work is built rather than a measured comparison: the clinic runs to schedule, the continuity is long, overnight call is light, and emergencies are rare. No survey has tested it. Neither instrument publishes a pediatric rheumatology row, and neither publishes an adult rheumatology row either. Medscape's 2024 report names only its ten highest and ten lowest specialties and rheumatology appears in neither, which is where the field's "mid-pack" reputation comes from rather than from a printed figure.¹⁰ So the only candidate proxy carrying a published number is general pediatrics, at 51% against that survey's own 49% all-physician average, and that is what this page reads, because the patients, the referral pattern, the children's-hospital setting and the payer mix here are pediatric while the adult version of the same immunology sees a different population in a different building. AMA's 2025 Organizational Biopsy, the free primary survey this site ranks from wherever it reaches, covers about fifteen fields and reaches none of the three at issue here. Read the lower-risk statement as a comparison of hours and acuity inside pediatrics rather than as a claim that this field measures below the physician average, which nothing published can show.¹⁰ ⟳

Career longevity is a genuine strength. The controllable schedule and cognitive (rather than physically punishing) nature support long careers. Retirements of an aging workforce are in fact part of the shortage problem, i.e., people tend to stay in it.²

Who's in the field (demographics)

Women: 81 of the 101 pediatric rheumatology fellows in AY2024-25 were women, 80.2%, well ahead of adult rheumatology's fellows at 63.8% and of pediatrics residents at 74.8%.¹¹ For the practicing workforce there is no figure: peds rheum sits far below the 2,500-active-physician floor of AAMC's Physician Specialty Data Report, so a count would have to come from the American Board of Pediatrics' workforce data book. ⟳
DO: ~30% of matched fellows (8 of 27, 2025), which is high and a direct consequence of undersubscription.⁴ ⟳
IMG/foreign: ~22% of matched fellows (6 of 27, 2025), because the persistent unfilled positions keep IMG share structurally elevated.⁴ ⟳
URiM / race-ethnicity: this page quotes no peds-rheum-specific breakdown. The nearest national source is ACGME's Active Residents/Fellows dashboard, which carries race and ethnicity by specialty for trainees. ⟳ Verify there before citing a figure.¹²

Culture, personality & the online stereotypes

Who gravitates here (the real pattern reflected in community and workforce perception; individuals vary, and plenty don't fit it):

The diagnostic-puzzle lover. Rheumatology's reputation across medicine is as the home of the cerebral, "zebra"-hunting, multi-system detective, and peds rheum inherits that fully: fevers of unknown origin, rashes-plus-joints-plus-labs, the kids other specialists couldn't crack. People who light up at ambiguity and pattern-synthesis self-select in.²
The patient, longitudinal type. Drawn to years-long relationships with chronically ill kids rather than quick fixes, and temperamentally patient, warm, and comfortable with slow disease arcs and uncertainty.²
The academic / thoughtful clinician. The field lives in children's hospitals; fellowship is research-heavy; CARRA (the Childhood Arthritis and Rheumatology Research Alliance) gives it a strongly collaborative, network-y research identity. It attracts people at home in a scholarly, guideline-building environment.²
The mission-driven. Because the unmet need is so visible, the field disproportionately draws people motivated by service and equity, including those who specifically want to serve kids who currently have no access.²

The stereotypes. Contested online perceptions rather than facts, each with a humanizing counterpoint:

"The cerebral introvert's specialty." The read online is soft-spoken academics who love a hard case. Counterpoint: directionally real, but not a gatekeeping requirement. There are busy, high-volume, community-adjacent clinicians who do it for the lifestyle-plus-kids without a research bone in their body.²
"You do it for love, not money." The jab: three extra fellowship years for general-peds pay. Counterpoint: it's an honest description more than an insult, and for people whose compass points at meaning and humane hours it's a feature, not a bug (see the FLI angle).²
"A tiny, isolated guild." Counterpoint: the U.S. workforce is measured in the low hundreds and everyone knows everyone, which cuts both ways: an intimate, tight-knit community, but a small world where you may be the only one for a long drive.²⁸

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, the recurring take is that peds rheum is intellectually one of the most rewarding pediatric subspecialties with an enviable, humane lifestyle, wrapped in two honest caveats repeated over and over: the pay is modest (often described as near general-peds level despite three extra fellowship years), and it's a small, under-recruited field in an outright workforce crisis, so many jobs are solo or small-group, sometimes far from other pediatric rheumatologists. The tone toward the field is affectionate and respectful; the tone toward its compensation and staffing is frustrated. A frequent summary sentiment: you do it because you love it rather than for the money, and if you love it, it is a wonderful life.²

Voices from the field. Paraphrased from public writing, with links to the originals:

Correll and colleagues (Pediatrics, 2024) document a per-capita workforce smaller than most pediatric subspecialties, at ~0.27 pediatric rheumatologists per 100,000 children in 2020, and name low salaries, lack of awareness, solo/small-group isolation, and retirements as the barriers to recruitment, while linking access directly to children's outcomes.⁸
Henrickson (Pediatric Rheumatology, 2011) argues demand has outstripped supply for well over a decade, that reimbursement and insurer behavior are structural barriers to chronic-disease care, and, strikingly, that educational debt was "an unexpectedly minor determinant" of whether trainees chose subspecialty careers; work-life balance and mission mattered more.⁸
Lakshminrusimha (Doximity Op-Med) lays out the "salary problem in pediatric subspecialties," the "READING" fields that earn below general pediatrics because they generate few procedures, and frames the compensation-vs-training mismatch as a driver of the pipeline collapse.⁵
Catenaccio and colleagues (Pediatrics / JAMA Pediatrics, 2021) quantify the uncomfortable truth: most pediatric subspecialties carry a negative lifetime financial return versus general peds, and the lower-earning fields also see worse workforce growth and access.⁹

Why people choose it / why people leave

Why choose it: you genuinely love complex, multi-system diagnostic reasoning and are energized (not stressed) by uncertainty · deep, long-term relationships with kids and families · a humane, mostly outpatient, low-overnight-acuity schedule with real control and part-time options · you get to see dramatic good outcomes, since biologics make this one of the most "rewarding results" fields in chronic pediatric care · you're mission-driven and want to work where the need is greatest · near-total job security and geographic freedom (see FLI angle).²⁸

Why leave or avoid it: the pay is modest and below general pediatrics, with three extra fellowship years for, on average, a negative lifetime return · six years post-MD before attending pay · no procedures, adrenaline, or acute rescue medicine · relentless prior-authorization/insurance paperwork to get biologics approved · geographic thinness, since jobs are where the gaps are and you may be the only one for miles · isolation as the sole or one of few pediatric rheumatologists at your site.²⁵

Best fit if: you're a patient, curious, relationship-oriented thinker who values meaning and lifestyle over maximum income, comfortable in academic/children's-hospital settings, and drawn to chronic-disease mastery and diagnostic puzzles.²

Not for you if: you need or want a high income (especially to retire heavy debt fast without a PSLF plan) · you want procedures, adrenaline, or acute high-stakes medicine · you dislike insurance/prior-auth paperwork · you need to live in one specific city · you'd feel isolated without nearby colleagues.²

The FLI angle — Pediatric Rheumatology for first-gen, low-income & immigrant students

This field has a genuinely unusual FLI profile: a low financial ceiling, but high accessibility, high job security, high mission-fit, and unusually strong loan-forgiveness compatibility. The honest work here is framing money vs. meaning with clear eyes.

Where peds rheum fits FLI realities well:

The door is wide open, and this is one of the more accessible fellowships in medicine. You enter through general pediatrics residency (an open route, and an unusually IMG-friendly one, though its DO share only matches the all-specialty average), and then apply to a fellowship that doesn't fill about half its spots every year. In 2025, ~30% of matched fellows were DOs and ~22% were IMG/foreign, a real and non-token lane driven purely by undersubscription. This is the opposite of fighting through a pedigree-gated, hyper-competitive match.⁶⁴
The loan math can be rescued, and this is the key FLI hack. Peds rheum jobs are overwhelmingly at academic medical centers and nonprofit (501(c)(3)) children's hospitals, the ideal employers for Public Service Loan Forgiveness (PSLF): 10 years of income-driven payments at a qualifying nonprofit wipes the federal balance tax-free. For someone with large loans and a modest salary, PSLF can neutralize much of the "negative return" problem on the federal balance, making this structurally one of the best PSLF fits in medicine. The geographic gaps also open NHSC / state loan-repayment options in underserved areas.² The word federal is doing real work in that sentence, and on this page more than most. Since July 2026 federal borrowing for medical school stops at $200,000, and school costs more than that almost everywhere, so a student starting now graduates with a private loan sitting beside the federal one and no program forgives it. A private loan sets its payment from the balance rather than from your income, so unlike the federal half it does not shrink to fit a $231,000 salary. That unforgivable slice is the part of the debt that genuinely argues for a higher-paying field, and it should be modeled separately before PSLF is treated as the answer to this page's headline problem.
Ironclad job security and the freedom to practice near home. The U.S. had only ~0.27 pediatric rheumatologists per 100,000 children in 2020, projected to reach just ~0.47 by 2040, a rise the study itself calls still inadequate.⁸ Shortages are worst in the South and West, and there are states with essentially no pediatric rheumatologist, where families drive hundreds of miles or wait months.⁸ For an FLI student this reframes geography as opportunity: you will always have a job, you can practice in your home community or an underserved area, and you'll be genuinely irreplaceable there.
Mission-fit for who FLI students often want to serve. The care gaps fall hardest on poor, uninsured, and minority children. If your reason for medicine is to serve the kinds of communities you came from, this field routes you straight at that need.⁸

Risks to name honestly:

The money is the real caution. You will likely not out-earn a general pediatrician, and you'll do it after three more years of training at fellow pay. Multiple peer-reviewed analyses find a negative lifetime return versus stopping at general peds. If fast debt payoff is your #1 goal, that is the single most important thing on this page.⁵⁹
It's a long road to a modest paycheck. Six years of post-MD training (3 residency + 3 fellowship), three of them at fellow pay, before an attending salary that sits below general peds. This is not the shortest path to attending life.³⁵
Geographic thinness cuts both ways. The shortage guarantees a job, but it can mean solo or small-group practice, potentially far from other pediatric rheumatologists, which is real isolation for someone who wanted community.²
A historical attrition caveat. Older training data found ~1 in 6 fellows didn't complete, with male IMGs at somewhat higher risk, so it is worth entering with clear expectations and good mentorship, which matters most for students without an insider map.¹³

Bottom line: You probably won't get rich, and you'll train three extra years for pay near a general pediatrician's, so if fast debt payoff is your top goal, know that going in. But the lifestyle is humane, the work is deeply meaningful, modern biologics let you actually reverse kids' suffering, PSLF fits this field beautifully for the federal half of your balance, and the shortage is so severe that you'll always have a job and can serve exactly the communities that need you most. Notably, the workforce literature found educational debt was an "unexpectedly minor" driver of whether trainees chose subspecialty careers, so with a real loan-forgiveness plan the money need not be the deciding factor. For the right person, that's one of the best deals in medicine.⁸

Subspecialties & where you can steer

None are separate boarded subspecialties; these are areas of clinical/research focus within the field.¹²

JIA & chronic arthritis. The largest disease group; the bread-and-butter of the field.
Lupus & connective-tissue disease. SLE, dermatomyositis, scleroderma, MCTD, Sjögren; the high-acuity, multi-organ end.
Autoinflammatory / periodic-fever syndromes. PFAPA and the monogenic periodic fevers; a fast-moving, genetics-rich frontier.
Uveitis. Co-managed with ophthalmology; a defining cross-disciplinary corner.
Vasculitis. Kawasaki disease, IgA vasculitis, ANCA-associated, Behçet.
Musculoskeletal / amplified pain syndromes. Chronic pain management with a heavy quality-of-life focus.
Research / CARRA-networked academic careers. Registry science, consensus treatment plans, and clinical trials are a genuine career track given how academic the field is.

Fun facts

Biologics turned it into a "results" specialty. Peds rheum went from a field managing decline to one that frequently achieves remission, a rare arc in chronic disease, and a big part of why practitioners love it.²
It's a genuinely small guild. The entire U.S. pediatric rheumatology workforce is measured in the low hundreds, so you could plausibly meet a large fraction of your whole specialty at one annual meeting.⁸
CARRA (the Childhood Arthritis and Rheumatology Research Alliance) makes this one of the most collaboratively research-networked pediatric fields, small enough that "everyone knows everyone."²
The shortage is structural, not cyclical. Demand has exceeded supply for well over a decade, and projections say it stays that way through 2040, so the "you'll always have a job" pitch is unusually durable.⁸
About 60% of children with rheumatic disease are seen by adult rheumatologists, many with minimal pediatric training, because there simply aren't enough pediatric specialists to go around.⁸
It's a "good lifestyle" field that pays like a mission field. The tension between its excellent quality of life and its modest pay is basically the defining feature of its reputation.²

Sources

What they do, settings, procedures, disease list, and subfields. American Academy of Pediatrics / HealthyChildren.org, "What is a Pediatric Rheumatologist?" https://www.healthychildren.org/English/family-life/health-management/pediatric-specialists/Pages/What-is-a-Pediatric-Rheumatologist.aspx ; American College of Rheumatology, "Pediatric Rheumatology" (patient resources), https://rheumatology.org/patients/pediatric-rheumatology ; Childhood Arthritis and Rheumatology Research Alliance (CARRA), https://carragroup.org/ (2026). ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Lifestyle, wellbeing, culture, day/week structure, decision framework, fun facts, and synthesized online sentiment (SDN, r/pediatrics, r/medicine — paraphrased, no verbatim quotes). Compiled mid-2026 from the workforce literature (Correll 2024; Henrickson 2011, both above), which characterizes the field as outpatient-dominant with work-life balance and part-time flexibility as central recruitment/retention themes, and from community sentiment. ZipRecruiter salary estimate (~$313k, treat as rough/high): https://www.ziprecruiter.com/Salaries/Pediatric-Rheumatologist-Salary (accessed 2025). Corrected 2026-08-17: the FLI section offered PSLF as the answer to this page's headline problem, the negative lifetime return, and drew that conclusion as though the whole balance were federal. Federal borrowing for medical school has stopped at $200,000 since July 2026, below what school costs almost anywhere, so the private slice beside it is unforgivable and its payment is set by the balance rather than by income. The section now names that, and the bottom line says which half PSLF reaches. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵ ↩¹⁶ ↩¹⁷ ↩¹⁸ ↩¹⁹ ↩²⁰ ↩²¹ ↩²² ↩²³ ↩²⁴ ↩²⁵ ↩²⁶ ↩²⁷ ↩²⁸ ↩²⁹ ↩³⁰
Training path, fellowship structure (3 yrs, ACGME/RCPSC-accredited, required scholarly activity), and board certification. American Board of Pediatrics, "Pediatric Rheumatology Certification" (updated Nov 25, 2025): https://www.abp.org/subspecialties/pediatric-rheumatology ; ACGME Pediatric Rheumatology program requirements (program #331), https://www.acgme.org/ ; AAP/HealthyChildren.org (as above). ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸
Fellowship match — fill rates, positions, DO/IMG composition, applicant interest trend. American College of Rheumatology press release, "2025 Rheumatology Fellowship Match Day — Fill Rates Remain Strong but Workforce Gaps Persist" (2025): https://rheumatology.org/press-releases/2025-rheumatology-fellowship-match-day-fill-rates-remain-strong-but-workforce-gaps-persist ; MDedge/The Hospitalist, "Rheumatology Match: Less than Half of Pediatric Positions Filled, Worsening Existing Trend": https://community.the-hospitalist.org/content/rheumatology-match-less-half-pediatric-positions-filled-worsening-existing-trend . Run via the NRMP Medicine & Pediatric Specialties Match, https://www.nrmp.org/ . The five-year series is NRMP's own trend table in Results and Data: Specialties Matching Service, 2026 Appointment Year, whose pediatric rheumatology row reads 44 positions at 54.5% (2026), 55 at 49.1% (2025), 52 at 61.5% (2024), 43 at 62.8% (2023) and 39 at 69.2% (2022): https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf . Program counts for 2026 and 2025 are the ACR's — "Total certified pediatric rheumatology programs decreased from 36 in 2025 to 33 in 2026" — and NRMP's trend table does not publish them for earlier years. Corrected 2026-08-17: the table's third row read "2023 | 52 positions | 32 filled | 62%". Those figures are the 2024 appointment year; NRMP's 2023 appointment year is 43 positions at 62.8%. The 52-and-32 pair came from an MDedge article that labels cycles by match year rather than appointment year, and mixing the two labels into one column made 2024 look absent when it was the row a reader was looking at. The table now prints NRMP's whole five-year appointment-year series, which shows the decline more plainly than three rows did. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³
Compensation — national figure, fellowship-penalty table, "READING" mnemonic, structural drivers, academic base band, and the adult-vs-peds contrast. Doximity, "2025 Physician Compensation Report" (2025, 2024 data): https://www.doximity.com/reports/physician-compensation-report/2025 , compiled in Becker's ASC, "Physician pay in 2026: 20 stats" (2026): https://www.beckersasc.com/asc-coding-billing-and-collections/physician-pay-in-2026-20-stats/ . Doximity Op-Med (Satyan Lakshminrusimha), "The Salary Problem in Pediatric Subspecialties" (2024/25): https://opmed.doximity.com/articles/the-salary-problem-in-pediatric-subspecialties . Adult rheumatology anchors (Medscape 2026 ~$284k; Doximity 2025 ~$325k) are carried, with their own citations, on the rheumatology profile on this site. Medicaid/reimbursement drag: Chartis, "Match Day 2024…" (2024): https://www.chartis.com/insights/match-day-2024-sees-record-numbers-reveals-potential-future-shortage-pediatrics . Assistant-professor base and state/regional tables: limited data — ⟳ verify against MGMA / SullivanCotter academic-medicine surveys (paywalled). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵
General pediatrics as an accessible base-residency route. NRMP, Results and Data: 2026 Main Residency Match, May 2026, Table 2, https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf . Pediatrics (categorical) offered 3,126 positions and filled 2,951 (94.4%). Of those filled, 623 went to US DO seniors and graduates (21.1%) and 897 to IMGs, US-citizen and non-US combined (30.4%). The all-PGY-1 baselines in the same table are 21.5% DO and 25.2% IMG of 38,354 filled positions, so pediatrics is at the DO average and well above it on IMG. Swept 2026-08-17: DO 21.1% and IMG 30.4%, both over the 2,951 categorical positions filled. This footnote read "Peds ~18% DO of PGY-1 positions; ~99% DO senior match success; ~840 IMGs matched" and pointed at the NRMP match-data landing page rather than a report, so none of the three could be checked: the ~840 pins the edition to the 2025 Match (841 IMGs), ~18% matches no cycle from 2022 to 2026 on either denominator, and the ~99% was an all-specialty DO senior placement rate rather than a pediatrics figure. An earlier correction here quoted 930 IMGs matched, which combines Pediatrics (Categorical) with Pediatrics (Primary) and so does not share a denominator with the 30.4%; the categorical-only count is 897. The two sentences citing this footnote called the pediatrics door "DO/IMG-friendly"; on these numbers only the IMG half holds. Peds Rheum's own fellowship shares, which run well above the residency on DO, are separate and are in ⁴. ⟳ ↩ ↩²
Applicant-to-position ratio (~0.62 in 2024, among the lowest of pediatric subspecialties). Lucile Packard Foundation for Children's Health, pediatric subspecialty workforce report (2024): https://lpfch.org/wp-content/uploads/2024/02/FINALM_1.pdf . ⟳ ↩
The workforce shortage — per-capita supply, geographic access deserts, academic concentration, and recruitment barriers. Correll CK, et al., "Child Health Needs and the Pediatric Rheumatology Workforce: 2020–2040," Pediatrics (2024), PMID 38300008: https://pubmed.ncbi.nlm.nih.gov/38300008/ (~0.27 per 100,000 children in 2020 → projected ~0.47 by 2040, still inadequate; South/West worst; low salaries, isolation, retirements as barriers; access linked to outcomes). Henrickson M., "Policy challenges for the pediatric rheumatology workforce" (Parts I & II), Pediatric Rheumatology Online Journal (2011), PMID 21843335: https://pubmed.ncbi.nlm.nih.gov/21843335/ (>72% at teaching hospitals; ~60% of pediatric rheumatic patients seen by adult rheumatologists; reimbursement barriers; debt an "unexpectedly minor determinant"; poor/uninsured/minority children underserved). Correll CK, et al., "2015 ACR Workforce Study," Arthritis Care & Research (2022), PMID 33107674: https://pubmed.ncbi.nlm.nih.gov/33107674/ . Exact count of states with zero pediatric rheumatologists: ⟳ verify against ACR/CARRA workforce maps. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴
Negative lifetime financial return for most pediatric subspecialties vs. general pediatrics, and the pay-vs-workforce correlation. Catenaccio E, et al., "Differences in Lifetime Earning Potential for Pediatric Subspecialists," Pediatrics (2021), PMID 33685988: https://pubmed.ncbi.nlm.nih.gov/33685988/ (12 of 15 subspecialties negative; best-vs-worst gap >$2.3M, 2018–19 data). Catenaccio E, et al., "Association of Lifetime Earning Potential and Workforce Distribution Among Pediatric Subspecialists," JAMA Pediatrics (2021), PMID 34180976: https://pubmed.ncbi.nlm.nih.gov/34180976/ . ⟳ ↩ ↩² ↩³
Cross-specialty burnout and happiness context. Medscape does not publish a line for a field this small. The burnout ranking is Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023), which is paywalled and is relayed here through Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) and Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout); it puts the all-physician average at 49% and lists neither adult nor pediatric rheumatology in its top or bottom ten, which is where "mid-pack" comes from. The "happy outside work" ranking that places rheumatology low comes from Medscape's 2024 lifestyle reporting by way of a secondary that does not link the underlying table, and nobody here has opened the primary report, so treat it as unverified. On whether rheumatologists would choose the field again: no one has published a would-choose-again figure by specialty since about 2019, so there is no number to cite. ⟳ ↩ ↩²
Women among pediatric rheumatology fellows: 81 of 101, 80.2%, in AY2024-25; adult rheumatology fellows 63.8%; pediatrics residents 74.8%. ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. Corrected 2026-08-13: this page estimated "well over 60–70%" and called the exact figure limited data. ACGME publishes it. ↩
Demographics. The field is female-majority, and pediatrics as a whole is the most female specialty in medicine: AAMC's 2025 Key Findings puts pediatrics at 66.7% women on 2024 data, https://www.aamc.org/data-reports/data/2025-key-findings . Corrected 2026-08-17: this footnote opened by quoting pediatrics at "~65% women overall per AAMC 2021" and then corrected itself to 66.7%, against a ~65% that appears nowhere on the page and had already been replaced. No source gives a %-women figure for peds rheumatologists in practice, and that gap stands. A figure for peds rheum fellows does exist and was missed by earlier passes: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf , puts pediatric rheumatology fellows at 80.2% women and adult rheumatology fellows at 63.8%. A fellow share and a workforce share count different people, so the 80.2% cannot stand in for the practicing figure. URiM breakdown: no by-specialty table is published; AAMC's 2025 Key Findings gives race and ethnicity for all active physicians in aggregate only. ⟳ ↩
Historical fellowship noncompletion (~16%, 1997–2007; male IMGs at somewhat higher attrition risk; concentration in specific programs). Riebschleger M, et al., "Noncompletion in Pediatric Rheumatology Fellowships," Journal of Graduate Medical Education (2014), PMID 24701329: https://pubmed.ncbi.nlm.nih.gov/24701329/ . ↩

Researched with AI assistance and reviewed by hand. How this site is made